Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65497 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Naloxegol Oxalate
CAS:<p>Applications Naloxegol Oxalate is an oxalate form of Naloxegol (N284470) which is a peripherally-selective opioid antagonist.<br>References Seifert, R., et al.: G Protein-Coupled Receptors as Drug Targets: Analysis of Activation and Constitutive Activity, 227 (2012)<br></p>Formula:C34H53NO11•C2H2O4Color and Shape:NeatMolecular weight:651.7990032-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol
CAS:Controlled Product<p>Applications 2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol is an impurity found in Mirtazapine (M365000). Mirtazapine Impurity B.<br></p>Formula:C17H21N3OColor and Shape:White To Off-WhiteMolecular weight:283.37Abemaciclib-d5
CAS:Controlled ProductFormula:C27D5H27F2N8Color and Shape:NeatMolecular weight:511.6241-Methoxy-Empagliflozin Tetraacetoxy
CAS:Formula:C32H37ClO12Color and Shape:NeatMolecular weight:649.0824-Desmethoxypropoxyl-4-chloro Rabeprazole
CAS:Controlled Product<p>Impurity Rabeprazole EP Impurity H (Lansoprazole EP Impurity F)<br>Applications 4-Desmethoxypropoxyl-4-chloro Rabeprazole (Rabeprazole EP Impurity H (Lansoprazole EP Impurity F)) is a process impurity of Rabeprazole (R070500).<br></p>Formula:C14H12ClN3OSColor and Shape:NeatMolecular weight:305.78N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamide
CAS:Controlled ProductFormula:C19H21N5OColor and Shape:WhiteMolecular weight:335.40Aprepitant-d4
CAS:Controlled Product<p>Applications Aprepitant-d4 is a labeled analogue of Aprepitant (A729800), A novel selective neurokinin-1 (NK-1) receptor antagonist. In vitro studies using human liver microsomes indicate that Aprepitant is metabolised primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19, and no metabolism by CYP2D6, CYP2C9, or CYP2E1. Aprepitant-d4 is a potential treatment for chemotherapy induced nausea and vomiting.<br>References Hale, J.J., et al.: J. Med. Chem., 41, 4607 (1998); Campos, D., et al.: J. Clin. Oncol., 19, 1759 (2001); Van Belle, S., et al.: Cancer, 94, 3032 (2002); Majumdar, A.K., et al.: J. Clin. Pharmacol., 46, 291 (2006)<br></p>Formula:C23H17D4F7N4O3Color and Shape:NeatMolecular weight:538.45cis-Tadalafil
CAS:Controlled Product<p>Impurity Tadalafil EP Impurity A<br>Applications The (6R)-cis-enantiomer of Tadalafil (T004500). Tadalafil Impurity (6R,12aS)<br>References Aldridge, J., et al.: Br. Med. J., 318, 669 (1999), Daugan, A., et al.: J. Med. Chem., 46, 4533 (2003), Vredenbregt, M., et al.: J. Pharm. Biomed. Anal., 40, 840 (2006),<br></p>Formula:C22H19N3O4Color and Shape:Off-WhiteMolecular weight:389.40Cyclopropanecarboxylic Acid
CAS:<p>Applications Cyclopropanecarboxylic Acid is used as a reagent in the synthesis of substituted 4-(thiophen-2-ylmethyl)-2H-phthalazin-1-ones as potent PARP-1 inhibitors. Also used as a reagent in the synthesis of 2-alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Wang, L., et al.: Bioorg. Med. Chem. Lett., 24, 3739 (2014); Keaney, E.P., et al.: Bioorg. Med. Chem. Lett., 24, 3714 (2014)<br></p>Formula:C4H6O2Color and Shape:NeatMolecular weight:86.09Methylphenidate Hydrochloride
CAS:Controlled Product<p>Applications Controlled substance (stimulant). CNS stimulant. Four isomers of Methylphenidate are known to exist. One pair of threo isomers and one pair of erythro are distinguished, from which only d-threo-Methylphenidate exhibits the pharmacologically usually desired effects. This compound is a 4:1 mixture of rac-erythro (M325670) and rac-threo (M325671).<br>References Greenblatt, E.N., et al.: J. Pharmacol. Exp. Ther., 131, 115 (1961), Padmanabhan, G.R., Anal. Profiles Drug Subs., 10, 473 (1981), Srinivas, N.R., et al.: Pharm. Res., 10, 14 (1993),<br></p>Formula:C14H19NO2·ClHColor and Shape:White To Off-WhiteMolecular weight:269.77N-Methyl Omeprazole (Mixture of isomers with the methylated nitrogens of imidazole)
CAS:Controlled Product<p>Applications Omeprazole (O635000) impurity.<br>References Allenmark, S., et al.: Anal. Biochem., 136, 293 (1984), Besancon, M., et al.: J. Biol. Chem., 272, 22438 (1997),<br></p>Formula:C18H21N3O3SColor and Shape:Off White SolidMolecular weight:359.44DL-Erythro Ritalinic Acid
CAS:Controlled Product<p>Applications A major metabolite of Methylphenidate.<br>References Redalieu, E., et al.: Drug Metab. Dispos., 10, 708 (1982), Brewer, E., et al.: J. Pharm. Sci., 87, 395 (1998), Shah, V., et al.: Pharm. Res., 17, 1551 (2000), Tanaka, N., et al.: Anal. Chem., 73, 420 (2001),<br></p>Formula:C13H17NO2Color and Shape:WhiteMolecular weight:219.284-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-iodo-2-methoxy-benzamide
CAS:<p>Impurity Amisulpride EP Impurity C<br>Applications 4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-iodo-2-methoxy-benzamide is an impurity of Amisulpride (A633250), an antipsychotic. Amisulpride is a dopamine receptor antagonist. (Amisulpride EP Impurity C). Dopamine imaging agent<br>References Protais, P., et al.: Neuropharmacol., 24, 861 (1985), Perrault, G., et al.: J. Pharmacol. Exp. Ther., 280, 73 (1997),<br></p>Formula:C15H22IN3O2Color and Shape:NeatMolecular weight:403.264-(3-methylthiophen-2-yl)-6-(thiophen-2-yl)pyrimidin-2-amine
CAS:Purity:95.0%Molecular weight:273.3699951171875Droperidol N-Oxide
CAS:Controlled Product<p>Applications Droperidol N-Oxide is a derivative of Droperidol (D679500), a D1, D2 dopamine receptor antagonist; butyrophenone antipsychotic and anti-emetic.<br>References Yelnosky, J., et al.: Toxicol. Appl. Pharmacol., 6, 37 (1964), Janicki, C.A., et al.: Anal. Profiles Drug Subs., 7, 171 (1978), Hamik, et al.: Cancer Chemother. Pharmacol., 24, 307 (1989), Heyer, E.J., et al.: Brain Res., 863, 20 (2000),<br></p>Formula:C22H22FN3O3Color and Shape:White To Off-WhiteMolecular weight:395.43N-Boc Linagliptin
CAS:Controlled Product<p>Applications N-Boc Linagliptin is an impurity of linagliptin (L465900), which is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.<br>References Prabavathy, N. et al.: Int. J. Pharm. Bio. Sci., 2, 438 (2011); Deacon, C.F.: Diab. Obes. Metab., 13, 7 (2011);<br></p>Formula:C30H36N8O4Color and Shape:NeatMolecular weight:572.66(S)-2-Hydroxy-3-methoxy-3,3-diphenylpropionic Acid
CAS:Controlled Product<p>Impurity Ambrisentan Hydroxy Acid Impurity<br>Applications (S)-2-Hydroxy-3-methoxy-3,3-diphenylpropionic Acid is used in analytical studies for chiral discrimination of α-functionalized acids. Ambrisentan Hydroxy Acid Impurity<br>References Jain, N., et al.: Tetrahedron, 70, 4343 (2014)<br></p>Formula:C16H16O4Color and Shape:NeatMolecular weight:272.30Ethyl 5-(4-chlorophenoxy)-1-cyano-4-hydroxyisoquinoline-3-carboxylate
CAS:Purity:techMolecular weight:368.7699890136719Ranolazine Dihydrochloride
CAS:<p>Stability Hygroscopic<br>Applications Ranolazine Dihydrochloride is an anti-ischemic agent which modulates myocardial metabolism. Antianginal.<br>References Chaitman, B.R., et al.: J. Am. Coll. Cardial., 43, 1375 (2004); McCormack, J.G., et al.: Gen. Pharmacol., 30, 639 (1998); Schofield, J.A.H., et al.: Expert Opin. Invest. Drugs, 11, 117 (2002)<br></p>Formula:C24H35Cl2N3O4Color and Shape:NeatMolecular weight:500.46Ondansetron-d3
CAS:Controlled Product<p>Applications Ondansetron-d3 is a labeled specific serotonin (5-HT3) receptor antagonist. Antiemetic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Kris, M.G., et al.: J. Clin. Oncol., 6, 659 (1988); Faris, P..L., et al.: Lances, 355, 792 (2000)<br></p>Formula:C18H16D3N3OColor and Shape:NeatMolecular weight:296.38(S)-2-(((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)(nitroso)amino)-3-methylbutanoic Acid
CAS:Controlled ProductFormula:C19H20N6O3Color and Shape:Light YellowMolecular weight:380.44-Chloro-1-chloromethyl-1H-pyrazole
CAS:Formula:C4H4Cl2N2Color and Shape:LiquidMolecular weight:150.994-Chloro-2-(4-chlorobenzoyl)-1-(4-methoxyphenyl)hydrazide Benzoic Acid
CAS:<p>Applications An impurity of the anti-inflammatory drug indomnethacin (I641000). Indomethacin inhibits cyclooxygenase (IC50=0.1uM) selectively over liposygenases (IC50=100uM for 5-,12- and 15-LO). A clinically useful NAISD.<br>References Salari, H., et al.: Prostagland. Leukotrienes Med., 13, 53 (1984), Lehmann, J.M., et al.: J. Biol. Chem., 272, 3406 (1997)<br></p>Formula:C21H16Cl2N2O3Color and Shape:NeatMolecular weight:415.27Levofloxacin-d3 Sodium Salt
CAS:Controlled Product<p>Applications Levofloxacin-d3 Sodium Salt, is the labeled analogue of Levofloxacin (L360000), an antibiotic used against gram-negative organisms.<br>References Kato, M., et al.: Arzneim.-Forsch., 42, 365 (1992), North, D.S., et al.: Pharmacotherapy, 18, 915 (1998), Hwang, D.G., et al.: Br. J. Ophthalmol., 87, 1004 (2003),<br></p>Formula:C18H16D3FN3NaO4Color and Shape:NeatMolecular weight:386.373-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinemethanol
CAS:Controlled ProductFormula:C9H10F3NO2Color and Shape:Light Beige To Light BrownMolecular weight:221.07(2E)-1-(1H-1,2,3-Benzotriazol-1-yl)-3-(thiophen-2-yl)prop-2-en-1-one
CAS:Molecular weight:255.3000030517578DL-Norepinephrine-d6 Hydrochloride, 85%
CAS:Controlled Product<p>Applications Antagonist of dibutyryl cyclic AMP in the regulation of narcosis. Norepinephrine modulates human dendritic cell activation by altering cytokine release.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Piguet, P., et al.: J. Exp. Med., 173, 673 (1991), Hosoi, J., et al.: Nature, 363, 159 (1993), Elenkov, I., et al.: Pharmacol. Rev., 52, 595 (2000), Kaplan, D., et al.: Immunity, 23, 611 (2005),<br></p>Formula:C82H6H5NO3·ClHPurity:85%Color and Shape:NeatMolecular weight:211.68Macitentan
CAS:Controlled Product<p>Applications Macitentan, is an orally active endothelin receptor antagonist used for pulmonary arterial hypertension.<br>References Emoto, N. Ensho to Men'eki, 20, 487 (2012);<br></p>Formula:C19H20Br2N6O4SColor and Shape:White To Off-WhiteMolecular weight:588.27Ref: 10-F212961
1g14.00€5g29.00€10gTo inquire25g57.00€50gTo inquire100gTo inquire250gTo inquire500gTo inquireLevocetirizine Dihydrochloride
CAS:<p>Levocetirizine Dihydrochloride is a third-gen antihistamine targeting H1-receptors, treating allergies and urticaria.</p>Formula:C21H27Cl3N2O3Purity:99.89%Color and Shape:White Or Off-White Crystalline PowderMolecular weight:461.81Dolutegravir Sodium
CAS:<p>Applications Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.<br>References Kobayashi, M. et al. Antimicrob Agents Chemother., 55, 813 (2011); Garrido, C. et al.: Antiviral, Res., 90, 164 (2011); Lenz, J.C.C. et al.: Exp. Opin. Invest. Drugs, 20, 537 (2011)<br></p>Formula:C20H18F2N3O5·NaColor and Shape:NeatMolecular weight:441.363,6-Diiodo-1H-indazole
CAS:Controlled Product<p>Applications 3,6-Diiodo-1H-indazole is used to prepare aryl-substituted indazole derivatives as modulators and inhibitors of protein kinases in the treatment of tumor growth, cellular proliferation, and angiogenesis.<br>References Kania, R., et al.: PCT Int. Appl., WO 2001002369 A2 20010111 (2001)<br></p>Formula:C7H4I2N2Color and Shape:NeatMolecular weight:369.93(2R,4R)-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolane-4-methanol 4-(4-Methylbenzenesulfonate)
CAS:Controlled ProductFormula:C21H20Cl2N2O5SColor and Shape:NeatMolecular weight:483.3651-(6,7-Dimethoxyphthalazin-1-yl)piperidin-4-yl ethylcarbamate
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:360.41400146484375Diminazene-13C2,15N4 Dihydrochloride (major)
CAS:<p>Applications Labelled Diminazene (D479550). Antiprotozoal (Trypanosoma, Babesia).<br>References Braithwaite, A.W.<br></p>Formula:C1213C2H17Cl2N315N4Color and Shape:Yellow To Dark YellowMolecular weight:360.2rac-Naproxen-13C,d3
CAS:Controlled Product<p>Applications Labelled Naproxen. An anti-inflammatory, analgesic, antipyretic. A non-steroidal anti-inflammatory.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Harrison, I.T., et al.: J. Med. Chem., 13, 203 (1970)<br></p>Formula:CC132H3H11O3Color and Shape:NeatMolecular weight:234.27Famotidine-d4 (Major)
CAS:Controlled Product<p>Applications Famotidine-d4 is the labeled analogue of Famotidine (F102250), a histamine H2-receptor antagonist. Antiulcerative.<br>References Takeda, M., et al.: Arzneim.-Forsch., 32, 734 (1982); Miwa, M., et al.: J. Clin. Pharmacol. Ther. Toxicol., 22, 214 (1984); Takabatke, T., et al.: Eur. J. Clin. Pharmacol., 28, 327 (1985)<br></p>Formula:C8H11D4N7O2S3Color and Shape:NeatMolecular weight:341.474,6-Bis(3,5-di(pyridin-4-yl)phenyl)-2-phenylpyrimidine
CAS:Purity:98%Molecular weight:616.728027343752-Methyl-4-(morpholin-4-yl)aniline
CAS:Formula:C11H16N2OPurity:97%Color and Shape:SolidMolecular weight:192.2622-Methyl-5-morpholin-4-ylmethyl-furan-3-carboxylic acid
CAS:Formula:C11H15NO4Purity:98%Color and Shape:SolidMolecular weight:225.2443-Chloro-4-pyridineboronic acid hydrate
CAS:Formula:C5H7BClNO3Purity:95.0%Color and Shape:SolidMolecular weight:175.38Methyl 2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)acetate
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:253.610000610351564-Morpholinophenylglyoxal hydrate
CAS:Purity:95%Color and Shape:SolidMolecular weight:237.25500488281253-(3,4-dimethylphenyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one
CAS:Purity:98%Molecular weight:282.3599853515625Nadolol-d9
CAS:Controlled Product<p>Applications Labelled Nadolol (N201052). β-Adrenergic blocker. Antihypertensive; antianginal.<br>References Dreyfuss, J., et al.: J. Clin. Pharmacol., 17, 300 (1977), Sibley, P.L., et al.: Toxicol. Appl. Pharmacol., 44, 379 (1978), Slusarek, L., et al.: Anal. Profiles Drug Subs., 9, 455 (1980),<br></p>Formula:C17H18D9NO4Color and Shape:NeatMolecular weight:318.46O-Desethyl Dapagliflozin tetraacetate)
CAS:<p>Applications Empagliflozin Tetraacetate is an Empagliflozin (E521510) impurity and is a reagent used to design and synthesize nitric oxide releasing derivatives of dapagliflozin which has potential antidiabetic and antithrombotic agents.<br>References Zheng, L., et al.: Bioorg. Med. Chem., 26, 3947 (2018)<br></p>Formula:C27H29ClO10Color and Shape:White To Off-WhiteMolecular weight:548.973-Pyridin-4-yl-quinoxaline-2-carboxylic acid ethyl ester
Purity:95.0%Molecular weight:279.29901123046875(S)-1-Boc-3-hydroxypiperidine
CAS:Controlled Product<p>Applications (S)-1-Boc-3-hydroxypiperidine is an important chiral intermediate for the synthesis of ibrutinib, an anticancer drug targeting B-cell malignancies. Synthesis of pharmaceutical intermediates including ibrutinib, the API of the newly approved drug Imbruvica, for the treatment of lymphoma.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Chen, L., et al.: Tetrahedron Lett., 58, 1644 (2017); Ju, X., et al.: Org. Process Res. Dev., 18, 827 (2014)<br></p>Formula:C10H19NO3Color and Shape:NeatMolecular weight:201.261-Benzhydrylpiperazine
CAS:Controlled ProductFormula:C17H20N2Color and Shape:White To BeigeMolecular weight:252.355-Hydroxy Dantrolene-d4
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A labelled metabolite of Dantrolene (D185000) that has shown to have muscle relaxant effects.<br>References Ellis, K.O., et al.: J. Med. Chem., 21, 127 (1977), Jayyosi, Z., et al.: Drug Metab. Dispos., 21, 939 (1993),<br></p>Formula:C14H6D4N4O6Color and Shape:NeatMolecular weight:334.28Agomelatine Dimer Urea
CAS:<p>Impurity Agomelatine Impurity 4<br>Applications Agomelatine Dimer Urea is an impurity of Agomelatine (A430020). Agomelatine Impurity 4<br>References Depreux, P., et al.: J. Med. Chem., 37, 3231 (1994); Wregget, K., et al.: J. Biol. Chem., 270, 22488 (1995); Ying, S., et al.: Eur. J. Pharmacol., 296, 33 (1996);<br></p>Formula:C27H28N2O3Color and Shape:NeatMolecular weight:428.52Dihydroxy Bendamustine Sodium Salt
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Dihydroxy Bendamustine is an impurity of Bendamustine (B132500).<br>References Watson, E., et al.: J. Pharm. Sci., 74, 1283 (1985), Teichert, J., et al.: Cancer Chemother. Pharmacol., 59, 759 (2007),<br></p>Formula:C16H22N3NaO4Color and Shape:NeatMolecular weight:343.35Hydroxymethoxy-N-desmethyl Toremifene
Formula:C26H28ClNO3Purity:>80%Color and Shape:NeatMolecular weight:437.96Tadalafil
CAS:Controlled Product<p>Stability Unstable in Methanol<br>Applications Tadalafil is used for the treatment of erectile dysfunction. A phosphodiesterase 5 inhibitor.<br>References Carrier, S., et al.: Can. J. Urol., 10(1), 12 (2003); Doggrell, S.A., et al.: Expert Opin. Pharmacother., 6, 75 (2005); Forgue, S.T., et al.: Br. J. Clin. Pharmacol., 61, 280 (2005);<br></p>Formula:C22H19N3O4Color and Shape:White To Off-WhiteMolecular weight:389.40Nitrendipine Propyl Ester
CAS:Controlled Product<p>Applications Nitrendipine Propyl Ester is an analogue of the antihypertensive drug Nitrendipine (N490150). Also, Nitrendipine Propyl Ester is an impurity of antihypertensive Lercanidipine (L179000). Lercanidipine impurity A.<br>References Ashimori, A., et al.: Chem. Pharm. Bull., 39, 108 (1991), Baindur, N., et al.: J. Med. Chem., 36, 3743 (1993), Zhang, B., et al.: Bioorg. Med. Chem. Lett., 20, 805 (2010),<br></p>Formula:C19H22N2O6Color and Shape:NeatMolecular weight:374.39(3-Fluoropyridin-4-yl)methanol
CAS:Formula:C6H6FNOPurity:95%Color and Shape:SolidMolecular weight:127.1182-Methylamino-1-morpholin-4-yl-ethanonehydrochloride
CAS:Purity:98.0%Color and Shape:SolidMolecular weight:194.66000366210938Terfenadine
CAS:Controlled Product<p>Applications Nonsedating-type histamine H1-receptor antagonist. Antihistaminic.<br>References Carr, A.A., et al.: Arzneim. Forsch., 32, 1157 (1982), Badwan, A.A., et al.: Anal. Profiles Drug Subs., 19, 627 (1990), Masheter, H.C., et al.: Clin. Rev. Allergy, 11, 5 (1993), Jurima-Romet, M., et al.: Drug Metab. Dispos., 22, 849 (1994),<br></p>Formula:C32H41NO2Color and Shape:White To Off-WhiteMolecular weight:471.671,1'-Bis(pyridin-4-ylmethyl)-1H,1'h-2,2'-biimidazole
CAS:Purity:98%Molecular weight:316.3680114746094Ethyl 1-(difluoromethyl)-5-methyl-1H-pyrazole-3-carboxylate
CAS:Purity:97.0%Molecular weight:204.1770019531251-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylic acid
CAS:Purity:95.0%Molecular weight:194.11300659179688Sodium (S)-6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide
CAS:Purity:95.0%Molecular weight:367.39999389648443-[(4-Fluorobenzyl)oxy]-2-thiophenecarbohydrazide
CAS:Formula:C12H11FN2O2SColor and Shape:SolidMolecular weight:266.294-(thiophen-2-yl)-6-(3,4,5-trimethoxyphenyl)pyrimidin-2-amine
CAS:Purity:95.0%Molecular weight:343.3999938964844ETHYL 1-CYCLOPROPYL-4-HYDROXY-6-OXO-1,6-DIHYDROPYRIDINE- 3-CARBOXYLATE
CAS:Purity:95.0%Molecular weight:223.22799682617188(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid
CAS:Controlled Product<p>Applications (R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid has been used as a reactant for the preparation of dipeptidyl peptidase-4 (DPP4) inhibitors for the treatment of type 2 diabetes, such as sitagliptin.<br>References Kim, H.J., et. al.: Bioorg. Med. Chem. Lett., 22, 5545 (2012)<br></p>Formula:C15H18F3NO4Color and Shape:NeatMolecular weight:333.30EPZ 6438
CAS:Controlled Product<p>Applications EPZ 6438 is a potent and selective inhibitor of EZH2.<br>References Knutson, S., et al.: Nat. Chem. Biol., 8, 890 (2012)<br></p>Formula:C34H44N4O4Color and Shape:NeatMolecular weight:572.747-Hydroxy Granisetron Hydrochloride
CAS:Controlled Product<p>Applications Granisetron (G780000) metabolite.<br>References Bloomer, J., et al.: Brit. J. Clin. Pharmacol., 38, 557 (1994), Vernekar, S.,e t al.: J. Med. Chem., 53, 2324 (2010),<br></p>Formula:C18H24N4O2·ClHColor and Shape:NeatMolecular weight:364.872-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:298.27301025390625
![N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FT283965.webp&w=3840&q=75)
![Methyl 5-(benzo[d][1,3]dioxol-5-yl)picolinate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF465604.webp&w=3840&q=75)
![4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-iodo-2-methoxy-benzamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FA609410.webp&w=3840&q=75)
![(S)-2-(((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)(nitroso)amino)-3-methylbutanoic Acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FT310923.webp&w=3840&q=75)
![4-[(3-BROMOPHENYL)AMINO]-6-ACRYLAMIDOQUINAZOLINE](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF527819.webp&w=3840&q=75)
![Sodium (S)-6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF219014.webp&w=3840&q=75)
![3-[(4-Fluorobenzyl)oxy]-2-thiophenecarbohydrazide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF010107.webp&w=3840&q=75)
